Final Regulatory Approval definition
Examples of Final Regulatory Approval in a sentence
With respect to those countries outside the United States in which EpiCept has obtained Final Regulatory Approval of the LidoPAIN(R) BP Product.
Subject to Section 3.4 herein, Endo shall commercialize the LidoPAIN(R) BP Product in the United States within six (6) months from the date on which LidoPAIN(R) BP Product receives Final Regulatory Approval in the United States so long as EpiCept shall have supplied Endo with quantities of the LidoPAIN(R) BP Product sufficient to commercially launch the Product as set forth in Endo's committed forecast delivered pursuant to the Supply Agreement.
Fresenius GmbH shall have the right to obtain Final Regulatory Approval in all jurisdictions within the Non-U.S. Territory in its own name and, where required by applicable law, in the name of any permitted distributor or sublicensee of Fresenius GmbH, and shall own all such Final Regulatory Approvals as are issued and all submissions as are made in connection therewith.
After Final Regulatory Approval is obtained for the Lead Product [***] as provided in Section [***], ownership of the NDA and all other regulatory filings for the Lead Product in the Territory, will be assigned by POZEN to GSK at no additional charge to GSK.
The provisions of this Section I-6(d) shall remain in full force and effect even if Final Regulatory Approval of the Three Agreements is not obtained.
Within [* *] following NDA Approval for the Lead Product [* *], GSK will notify POZEN in writing of [* *], GSK will use Commercially Reasonable Efforts to initiate Commercial Launch of the Lead Product in the Territory as soon as commercially practicable after Final Regulatory Approval is granted, [* *] (excluding delays not within GSK’s control, if any, related to manufacturing issues or the requirements of the FDA), in accordance with the Product Launch Plan and Commercialization Plan.
After Final Regulatory Approval is obtained for the Lead Product [* *] as provided in Section [* *], ownership of the NDA and all other regulatory filings for the Lead Product in the Territory, will be assigned by POZEN to GSK at no additional charge to GSK.
The approved costs of obtaining Final Regulatory Approval in the Non-U.S. Territory shall be included in budgets for Research and Development and Clinical Trials Costs for the Non-U.S. Territory and shall be reimbursed to Fresenius AG out of Non-U.S. Cash Flow in accordance with the terms of this Agreement.
Endo shall, either through a Marketing Partner(s) or on its own, commercialize the LidoPAIN(R) BP Product in each such country within *** from the date on which LidoPAIN(R) BP receives Final Regulatory Approval in the United States.
Endo shall, either through a Marketing Partner(s) or on its own, commercialize the LidoPAIN(R) BP Product in each such country within three (3) years from the date on which LidoPAIN(R) BP receives Final Regulatory Approval in the United States.